Cargando…

Inactivating CUX1 mutations promote tumorigenesis

A major challenge for cancer genetics is to determine which low frequency somatic mutations are drivers of tumorigenesis. Here we interrogate the genomes of 7,651 diverse human cancers to identify novel drivers and find inactivating mutations in the homeodomain transcription factor CUX1 (cut-like ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Chi C., Martincorena, Inigo, Rust, Alistair G., Rashid, Mamunur, Alifrangis, Constantine, Alexandrov, Ludmil B., Tiffen, Jessamy C., Kober, Christina, Green, Anthony R., Massie, Charles E., Nangalia, Jyoti, Lempidaki, Stella, Döhner, Hartmut, Döhner, Konstanze, Bray, Sarah J., McDermott, Ultan, Papaemmanuil, Elli, Campbell, Peter J., Adams, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874239/ https://www.ncbi.nlm.nih.gov/pubmed/24316979 http://dx.doi.org/10.1038/ng.2846

Ejemplares similares

Generating realistic null hypothesis of cancer mutational landscapes using SigProfilerSimulator
por: Bergstrom, Erik N., et al.
Publicado: (2020)

Pathway-based dissection of the genomic heterogeneity of cancer hallmarks’ acquisition with SLAPenrich
por: Iorio, Francesco, et al.
Publicado: (2018)

EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position Paper
por: Macintyre, Elizabeth, et al.
Publicado: (2020)

BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib
por: Ranzani, Marco, et al.
Publicado: (2015)

Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
por: Kampa-Schittenhelm, Kerstin Maria, et al.
Publicado: (2013)

Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
por: Gallagher, Stuart J, et al.
Publicado: (2015)

getITD for FLT3-ITD-based MRD monitoring in AML
por: Blätte, Tamara J., et al.
Publicado: (2019)

Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome—excess blasts detected by next-generation sequencing technique
por: Owattanapanich, Weerapat, et al.
Publicado: (2021)

P416: DNA METHYLATION-BASED CHARACTERIZATION OF ACUTE MYELOID LEUKEMIA POINTS TOWARDS KDM3B AS A 5Q HAPLOINSUFFICIENCY CANDIDATE
por: Kelly, Katherine, et al.
Publicado: (2023)

Adenoma development in familial adenomatous polyposis and MUTYH‐associated polyposis: somatic landscape and driver genes
por: Rashid, Mamunur, et al.
Publicado: (2015)

P440: ENHANCER HIJACKING IN COMPLEX-KARYOTYPE AML
por: Sollier, Etienne, et al.
Publicado: (2023)

Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia
por: Kampa-Schittenhelm, Kerstin Maria, et al.
Publicado: (2013)

CUX2 functions as an oncogene in papillary thyroid cancer
por: Sun, Yihan, et al.
Publicado: (2018)

The DNA repair function of CUX1 contributes to radioresistance
por: Ramdzan, Zubaidah M., et al.
Publicado: (2017)

CUX1, A Controversial Player in Tumor Development
por: Liu, Ning, et al.
Publicado: (2020)

Genomic studies controvert the existence of the CUX1 p75 isoform
por: Krishnan, Manisha, et al.
Publicado: (2022)

Sex bias of females in survival from cancer and infections. Is X the answer?
por: Emran, Abdullah Al, et al.
Publicado: (2021)

The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response()
por: Garnett, Mathew J, et al.
Publicado: (2014)

Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma
por: Tiffen, Jessamy, et al.
Publicado: (2016)

Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
por: Stegelmann, Frank, et al.
Publicado: (2020)

Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
por: Stegelmann, Frank, et al.
Publicado: (2021)

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
por: Punnia-Moorthy, Gaya, et al.
Publicado: (2021)

Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markers
por: Lueck, Sonja C., et al.
Publicado: (2016)

Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
por: Gowrishankar, Kavitha, et al.
Publicado: (2015)

Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations
por: Brammeld, Jonathan S., et al.
Publicado: (2017)

The role of CUX1 in antagonizing NF-κB signaling in TAMs
por: Kühnemuth, Benjamin, et al.
Publicado: (2014)

The AML-associated K313 mutation enhances C/EBPα activity by leading to C/EBPα overexpression
por: Gentle, Ian Edward, et al.
Publicado: (2021)

The Renovated Face of EHA Classical Master Class: A Survey-based Evaluation on Behalf of the EHA Campus Working Group
por: Gurnari, Carmelo, et al.
Publicado: (2022)

Unified classification and risk-stratification in Acute Myeloid Leukemia
por: Tazi, Yanis, et al.
Publicado: (2022)

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
por: Ju, Young Seok, et al.
Publicado: (2014)

The Transcription Factor Cux1 Regulates Dendritic Morphology of Cortical Pyramidal Neurons
por: Li, Ning, et al.
Publicado: (2010)

RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage
por: Ramdzan, Zubaidah M., et al.
Publicado: (2014)

Cux2 Activity Defines a Subpopulation of Perinatal Neurogenic Progenitors in the Hippocampus
por: Yamada, Makiko, et al.
Publicado: (2015)

CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors
por: Krug, Sebastian, et al.
Publicado: (2020)

Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo
por: Tiffen, Jessamy C, et al.
Publicado: (2010)

SEURAT: Visual analytics for the integrated analysis of microarray data
por: Gribov, Alexander, et al.
Publicado: (2010)

Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
por: Zhai, Yanan, et al.
Publicado: (2022)

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
por: Hirsch, Susanne, et al.
Publicado: (2017)

S136: ANALYSIS OF FACTORS ASSOCIATED WITH LONG-TERM SURVIVAL IN A LARGE ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENT COHORT: A HARMONY ALLIANCE STUDY
por: Guarnera, Luca, et al.
Publicado: (2023)

Cux2 refines the forelimb field by controlling expression of Raldh2 and Hox genes
por: Ueda, Shogo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_94007blg1eut3uevofe40mqj9m